首页> 外国专利> Anticonvulsant amino acids for the treatment of obsessive-compulsive neurosis

Anticonvulsant amino acids for the treatment of obsessive-compulsive neurosis

机译:抗惊厥氨基酸治疗强迫症神经症

摘要

The present invention describes the use of a compound of the following formula (I) for the manufacture of a medicament effective in the treatment or prevention of bipolar disease of a mammal: CHEM wherein R is hydrogen or lower alkyl, lower alkenyl, lower alkynyl, aryl, aryl lower alkyl, heterocyclic, heterocyclic lower alkyl, lower alkyl heterocyclic, lower cycloalkyl, lower cycloalkyl lower alkyl, each optionally substituted with at least one electron withdrawing or electron donating group; R1  is hydrogen or lower alkyl, lower alkenyl, lower alkynyl, aryl lower alkyl, aryl, heterocyclic lower alkyl, heterocyclic, lower alkyl heterocyclic, lower cycloalkyl, lower cycloalkyl lower alkyl, each optionally substituted with an electron donating or an electron withdrawing group; R2 and R3   are independently hydrogen, lower alkyl, lower alkenyl, lower alkynyl, aryl lower alkyl, aryl, halogen, heterocyclic, heterocyclic lower alkyl, lower alkyl heterocyclic, lower cycloalkyl, lower cycloalkyl lower alkyl, or Z-Y; R2 and R3 are optionally substituted with at least one electron withdrawing or electron donating group; Z is O, S, S(O)a, NR4 or PR4; Y is hydrogen, lower alkyl, aryl, aryl lower alkyl, lower alkenyl, lower alkynyl, heterocyclic, heterocyclic lower alkyl, and Y is optionally substituted with an electron donating or electron withdrawing group, or ZY  taken together is NR4NR5R7, NR4OR5, ONR4R7, OPR4R5, PR4OR5, SNR4R7, NR4SR7, SPR4R5, PR4SR7, NR4PR5R6, PR4NR5R7, NR4C(=O)R5, S(C=O)R5, NR4C(=O)OR5, or S(C=O)OR5, R4, R5 and R6   are independently hydrogen or lower alkyl, aryl, aryl lower alkyl, lower alkenyl, or lower alkynyl, each optionally substituted with an electron withdrawing or an electron donating group; R7  is COOR8, COR8, hydrogen or lower alkyl, aryl, aryl lower alkyl, lower alkenyl or lower alkynyl, each optionally substituted with an electron withdrawing or electron donating group; R8  is hydrogen, lower alkyl or aryl lower alkyl, the aryl or alkyl group is optionally substituted with an electron withdrawing or an electron donating group; n is 1-4; and a is 1-3.
机译:本发明描述了下式(I)化合物在制备对哺乳动物的双相性疾病有效治疗或预防的药物中的用途:其中R为氢或低级烷基,低级烯基,低级烯基。炔基,芳基,芳基低级烷基,杂环,杂环低级烷基,低级烷基杂环,低级环烷基,低级环烷基低级烷基,各自任选地被至少一个吸电子或供电子基团取代; R1是氢或低级烷基,低级烯基,低级炔基,芳基低级烷基,芳基,杂环低级烷基,杂环,低级烷基杂环,低级环烷基,低级环烷基低级烷基,各自任选地被供电子或吸电子基团取代; R2和R3独立地是氢,低级烷基,低级烯基,低级炔基,芳基低级烷基,芳基,卤素,杂环,杂环低级烷基,低级烷基杂环,低级环烷基,低级环烷基低级烷基或Z-Y; R2和R3任选地被至少一个吸电子或给电子基团取代; Z是O,S,S(O)a,NR4或PR4; Y是氢,低级烷基,芳基,芳基低级烷基,低级烯基,低级炔基,杂环,杂环低级烷基,并且Y任选地被给电子或吸电子基团取代,或者ZY一起是NR4NR5R7,NR4OR5,ONR4R7, OPR4R5,PR4OR5,SNR4R7,NR4SR7,SPR4R5,PR4SR7,NR4PR5R6,PR4NR5R7,NR4C(= O)R5,S(C = O)R5,NR4C(= O)OR5或S(C = O)OR5,R4,R5 R6独立地是氢或低级烷基,芳基,芳基低级烷基,低级烯基或低级炔基,各自任选地被吸电子或给电子基团取代; R7是COOR8,COR8,氢或低级烷基,芳基,芳基低级烷基,低级烯基或低级炔基,各自任选地被吸电子或供电子基团取代; R8是氢,低级烷基或芳基低级烷基,该芳基或烷基任选地被吸电子或给电子基团取代; n是1-4;和是1-3。

著录项

  • 公开/公告号EP1695703B1

    专利类型

  • 公开/公告日2010-08-11

    原文格式PDF

  • 申请/专利权人 RESEARCH CORPORATION TECHNOLOGIES INC.;

    申请/专利号EP20060012400

  • 发明设计人 HARRIS ROBERT H.;

    申请日2001-08-24

  • 分类号A61K31/16;A61K31/165;A61P29;A61K31/195;

  • 国家 EP

  • 入库时间 2022-08-21 18:39:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号